GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (NAS:PACB) » Definitions » Cyclically Adjusted PB Ratio

PACB (Pacific Biosciences of California) Cyclically Adjusted PB Ratio : 0.66 (As of May. 29, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Pacific Biosciences of California Cyclically Adjusted PB Ratio?

As of today (2025-05-29), Pacific Biosciences of California's current share price is $1.10. Pacific Biosciences of California's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 was $1.66. Pacific Biosciences of California's Cyclically Adjusted PB Ratio for today is 0.66.

The historical rank and industry rank for Pacific Biosciences of California's Cyclically Adjusted PB Ratio or its related term are showing as below:

PACB' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.54   Med: 5.54   Max: 34
Current: 0.54

During the past years, Pacific Biosciences of California's highest Cyclically Adjusted PB Ratio was 34.00. The lowest was 0.54. And the median was 5.54.

PACB's Cyclically Adjusted PB Ratio is ranked better than
82.06% of 496 companies
in the Medical Devices & Instruments industry
Industry Median: 1.825 vs PACB: 0.54

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pacific Biosciences of California's adjusted book value per share data for the three months ended in Mar. 2025 was $0.305. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is $1.66 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pacific Biosciences of California Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Pacific Biosciences of California's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Biosciences of California Cyclically Adjusted PB Ratio Chart

Pacific Biosciences of California Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 17.56 15.36 5.88 6.43 1.11

Pacific Biosciences of California Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.38 0.85 1.04 1.11 0.71

Competitive Comparison of Pacific Biosciences of California's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Pacific Biosciences of California's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Biosciences of California's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's Cyclically Adjusted PB Ratio falls into.


;
;

Pacific Biosciences of California Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Pacific Biosciences of California's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.10/1.66
=0.66

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Biosciences of California's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Pacific Biosciences of California's adjusted Book Value per Share data for the three months ended in Mar. 2025 was:

Adj_Book=Book Value per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.305/134.9266*134.9266
=0.305

Current CPI (Mar. 2025) = 134.9266.

Pacific Biosciences of California Quarterly Data

Book Value per Share CPI Adj_Book
201506 0.451 100.684 0.604
201509 0.546 100.392 0.734
201512 0.919 99.792 1.243
201603 1.021 100.470 1.371
201606 1.192 101.688 1.582
201609 1.066 101.861 1.412
201612 0.914 101.863 1.211
201703 0.740 102.862 0.971
201706 1.003 103.349 1.309
201709 0.872 104.136 1.130
201712 0.740 104.011 0.960
201803 0.779 105.290 0.998
201806 0.648 106.317 0.822
201809 0.886 106.507 1.122
201812 0.759 105.998 0.966
201903 0.621 107.251 0.781
201906 0.495 108.070 0.618
201909 0.333 108.329 0.415
201912 0.359 108.420 0.447
202003 0.392 108.902 0.486
202006 0.268 108.767 0.332
202009 0.720 109.815 0.885
202012 1.745 109.897 2.142
202103 1.415 111.754 1.708
202106 1.298 114.631 1.528
202109 3.812 115.734 4.444
202112 3.579 117.630 4.105
202203 3.275 121.301 3.643
202206 3.034 125.017 3.274
202209 2.774 125.227 2.989
202212 2.485 125.222 2.678
202303 2.771 127.348 2.936
202306 2.563 128.729 2.686
202309 2.956 129.860 3.071
202312 2.619 129.419 2.730
202403 2.384 131.776 2.441
202406 1.808 132.554 1.840
202409 1.655 133.029 1.679
202412 1.721 133.157 1.744
202503 0.305 134.927 0.305

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pacific Biosciences of California  (NAS:PACB) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Pacific Biosciences of California Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Pacific Biosciences of California's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Biosciences of California Business Description

Traded in Other Exchanges
Address
1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on designing, developing, and manufacturing sequencing solutions that enable scientists and clinical researchers to improve their understanding of the genome and ultimately, resolve genetically complex problems. It operates in, one reportable segment: the development, manufacturing, and marketing of an integrated platform for genetic analysis. The majority of the company's revenue is derived from Americas, followed by Asia-Pacific and Europe Middle East, and Africa.
Executives
Michele Farmer officer: Chief Accounting Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Oene Mark Van officer: Chief Operating Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Christian O Henry director 9885 TOWNE CENTRE DRIVE, SAN DIEGO CA 92121
Jeff Eidel officer: See Remarks 1305 O'BRIEN DR., MENLO PARK CA 94025
David W Meline director 3M COMPANY, 3M OFFICE OF GENERAL COUNSEL, ST PAUL MN 55144-1000
Susan G. Kim officer: Chief Financial Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
William W. Ericson director 777 MARINERS ISLAND BOULEVARD, SUITE 550, SAN MATEO CA 94404
Peter Fromen officer: Chief Commercial Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Hannah Valantine director 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Michael Hunkapiller director 400 HAMILTON AVENUE, 4TH FLOOR, PALO ALTO CA 94301
Eric Schaefer officer: VP Chief Accounting Officer 1305 O'BRIEN DRIVE, MENLO PARK CA 94025
Kathy Ordonez director 3 GIRALDA FARMS, C/O QUEST DIAGNOSTICS, MADISON NJ 07940
Randall S Livingston director
Lucy Shapiro director 10210 GENETIC CENTER COURT, SAN DIEGO CA 92121
David Botstein director 1380 WILLOW ROAD, PACIFIC BIOSCIENCES OF CALIFORNIA INC, MENLO PARK CA 94025